AI Insight
This research demonstrates that engineered enzymes can catalyze stereoselective carbon-sulfur bond formation through a carbene transfer mechanism. The study reveals that the enzyme operates through a dichotomic pathway, meaning it can proceed through two distinct mechanistic routes to form C(sp3)-S bonds with high stereoselectivity. This represents a novel enzymatic approach to creating chiral organosulfur compounds, which are important building blocks in pharmaceutical chemistry.
Why it matters
This enzymatic method offers a more sustainable and selective alternative to traditional metal-based catalysts for synthesizing sulfur-containing molecules. The ability to control stereochemistry through enzyme engineering has significant implications for pharmaceutical development, where the three-dimensional arrangement of atoms critically affects drug efficacy and safety.
